Eris Lifesciences betting on insulin expertise to boost its GLP-1 play
Published on: Aug. 6, 2025, midnight | Source: Livemint
Eris Lifesciences is using its growing insulin business to position itself as a serious contender in India’s fast-expanding diabetes and obesity drug market.
